Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI; Revenue Beat was 'Remarkable'
Tweet Send to a Friend
Evercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
